Cargando…

A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China

Background: SARS-CoV-2 infection causes immune response and produces protective antibodies, and these changes may persist after patients discharged from hospital. Methods: This study conducted a one-year follow-up study on patients with COVID-19 to observe the dynamic changes of circulating leukocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Renjie, Zhao, Bennan, Lan, Lijuan, Liu, Yaling, Li, Yalun, Jiang, Liangshuang, Dai, Shuiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339420/
https://www.ncbi.nlm.nih.gov/pubmed/35919814
http://dx.doi.org/10.7150/ijms.71286
_version_ 1784760183180754944
author Xu, Renjie
Zhao, Bennan
Lan, Lijuan
Liu, Yaling
Li, Yalun
Jiang, Liangshuang
Dai, Shuiping
author_facet Xu, Renjie
Zhao, Bennan
Lan, Lijuan
Liu, Yaling
Li, Yalun
Jiang, Liangshuang
Dai, Shuiping
author_sort Xu, Renjie
collection PubMed
description Background: SARS-CoV-2 infection causes immune response and produces protective antibodies, and these changes may persist after patients discharged from hospital. Methods: This study conducted a one-year follow-up study on patients with COVID-19 to observe the dynamic changes of circulating leukocyte subsets and virus-specific antibodies. Results: A total of 66 patients with COVID-19 and 213 healthy patients with inactivated SARS-CoV-2 vaccination were included. The virus-specific total antibody, IgG and IgM antibody of patients after one year of recovery were higher than those of healthy vaccinated participants (94.13 vs 4.65, 2.67 vs 0.44, 0.09 vs 0.06, respectively) (P < 0.001). Neutrophil count (OR = 1.73, 95% CI: 1.10-2.70, P = 0.016) and neutrophil-to-lymphocyte ratio (OR = 1.59, 95% CI: 1.05-2.41, P = 0.030) at discharge were the influencing factors for the positivity of virus-specific IgG antibody in patients after one year of recovery. The counts of CD4+ and CD8+ T, B and NK cells increased with the time of recovery, and remained basically stable from 9 to 12 months after discharge. After 12 months, the positivity of IgG antibody was 85.3% and IgM was 11.8%, while the virus-specific antibody changed dynamically in patients within one year after discharge. Conclusions: The SARS-CoV-2 specific antibody of recovered patients showed dynamic fluctuation after discharge, while the leukocyte subsets gradually increased and basically stabilized after 9 months.
format Online
Article
Text
id pubmed-9339420
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-93394202022-08-01 A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China Xu, Renjie Zhao, Bennan Lan, Lijuan Liu, Yaling Li, Yalun Jiang, Liangshuang Dai, Shuiping Int J Med Sci Research Paper Background: SARS-CoV-2 infection causes immune response and produces protective antibodies, and these changes may persist after patients discharged from hospital. Methods: This study conducted a one-year follow-up study on patients with COVID-19 to observe the dynamic changes of circulating leukocyte subsets and virus-specific antibodies. Results: A total of 66 patients with COVID-19 and 213 healthy patients with inactivated SARS-CoV-2 vaccination were included. The virus-specific total antibody, IgG and IgM antibody of patients after one year of recovery were higher than those of healthy vaccinated participants (94.13 vs 4.65, 2.67 vs 0.44, 0.09 vs 0.06, respectively) (P < 0.001). Neutrophil count (OR = 1.73, 95% CI: 1.10-2.70, P = 0.016) and neutrophil-to-lymphocyte ratio (OR = 1.59, 95% CI: 1.05-2.41, P = 0.030) at discharge were the influencing factors for the positivity of virus-specific IgG antibody in patients after one year of recovery. The counts of CD4+ and CD8+ T, B and NK cells increased with the time of recovery, and remained basically stable from 9 to 12 months after discharge. After 12 months, the positivity of IgG antibody was 85.3% and IgM was 11.8%, while the virus-specific antibody changed dynamically in patients within one year after discharge. Conclusions: The SARS-CoV-2 specific antibody of recovered patients showed dynamic fluctuation after discharge, while the leukocyte subsets gradually increased and basically stabilized after 9 months. Ivyspring International Publisher 2022-06-27 /pmc/articles/PMC9339420/ /pubmed/35919814 http://dx.doi.org/10.7150/ijms.71286 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Xu, Renjie
Zhao, Bennan
Lan, Lijuan
Liu, Yaling
Li, Yalun
Jiang, Liangshuang
Dai, Shuiping
A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title_full A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title_fullStr A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title_full_unstemmed A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title_short A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
title_sort one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with covid-19 in sichuan, china
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339420/
https://www.ncbi.nlm.nih.gov/pubmed/35919814
http://dx.doi.org/10.7150/ijms.71286
work_keys_str_mv AT xurenjie aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT zhaobennan aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT lanlijuan aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT liuyaling aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT liyalun aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT jiangliangshuang aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT daishuiping aoneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT xurenjie oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT zhaobennan oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT lanlijuan oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT liuyaling oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT liyalun oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT jiangliangshuang oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina
AT daishuiping oneyearfollowupstudyondynamicchangesofleukocytesubsetsandvirusspecificantibodiesofpatientswithcovid19insichuanchina